Pharmaceutical
Explore FY2026 financial trends, industry metrics, and company rankings across 82 Japanese listed Pharmaceutical companies.
Industry trend chart
Compare annual trends by metric group.
Implied share price and market capitalization are estimated from EDINET filing data, not real-time market prices.
※ Deposits, lending, and securities investment have a large impact on financial companies, so FCF, FCF margin, and FCF growth may not be suitable for simple comparisons with other industries.
Industry summary
Combined revenue reached ¥17.86 trillion, median operating margin was 3.5%, and median ROE was 1.4%. combined revenue increased 122.8% from the previous fiscal year.
Revenue leaders include Takeda Pharmaceutical Company Limited, Otsuka Holdings Co., Ltd., and Astellas Pharma Inc. .
Industry metrics by year
Review yearly trends by metric in a table.
Company list
Choose a fiscal year to inspect companies.
Implied share price and market capitalization are estimated from EDINET filing data, not real-time market prices.
Source: FSA EDINET / Data and metrics: bestforever.jp
New EDINET filings are typically imported within minutes, with financial data and analysis results updated accordingly.